While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its ...
Robert Roberson faces execution in Texas on Oct. 16 for the 2002 murder of his young daughter Nikki Curtis. For years, a growing pool of supporters — from the lead detective in his case to Dr. Phil — ...
FILE - This undated photo provided by the Wenatchee Police Department shows Travis Caleb Decker, who is wanted in connection with the deaths of his three daughters. (Wenatchee Police Department via AP ...
Cadillac is making a comeback thanks to its new EV lineup. The luxury brand had its best first-half sales this year since 2008. After launching a series of new electric SUVs earlier this year, ...
Newly released data from a crucial national test revealed historically low scores in two major subjects for 12th graders across the country, further emphasizing that U.S. students have struggled to ...
High school seniors had the worst reading scores since 1992 on a national test, a loss probably related to increases in screen time and the pandemic. Their math scores fell as well. By Dana Goldstein ...
PULLMAN, Wash. — Washington State University football fans showed up to support the Cougs at a tailgate Saturday afternoon. Some had family members on the team and others traveled from out of town to ...
Technology developed at Case Western Reserve University can restore a sense of touch that makes a prosthetic hand feel like a part of one’s own body instead of feeling artificial and disconnected. Now ...
Latest algorithm (Shield V2) has sensitivity of 84% for colorectal cancer with specificity of 90%, with stage I sensitivity of 62% Performance of the Shield algorithm was validated in expanded ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has met its targeted enrollment for the NIGHTINGALE trial, which ...
Dynavax’s lofty ambition to snatch Shingrix’s crown got off to a promising start after the biopharma’s investigational shingles vaccine held its own against GSK’s mainstay in the first part of a phase ...
The inherent variability and potential inaccuracies of AI-generated output can leave even experienced clinicians uncertain about AI recommendations. This dilemma is not novel; it mirrors the broader ...